Cellular immune mechanisms in myocarditis

Herz

Volumn 37, Issue 8, 2012, Pages 830-835

  Noutsias, M ^a   Patil, V J ^a   Maisch, B ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

Dilated cardiomyopathy; Endomyocardial biopsy; Immune system; Inflammatory cardiomyopathy; Macrophages; Myocarditis; T cells

Indexed keywords

AUTOANTIBODY; BETA1 INTEGRIN; CD11B ANTIGEN; CD3 ANTIGEN; CD45RO ANTIGEN; CD68 ANTIGEN; CYCLIN DEPENDENT KINASE 1; EOMESODERMIN; GAMMA INTERFERON; GRANZYME B; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 27; INTERLEUKIN 4; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PERFORIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; CYTOKINE;

ANTIVIRAL ACTIVITY; ARTICLE; AUTOIMMUNITY; CELLULAR IMMUNITY; COXSACKIE VIRUS; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC PROCEDURE; DIGITAL IMAGING; GENE EXPRESSION; HEART MUSCLE BIOPSY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 6; HUMAN PARVOVIRUS B19; HUMORAL IMMUNITY; IMAGE ANALYSIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; MYOCARDITIS; PATIENT SELECTION; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RELIABILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; TH1 CELL; TH17 CELL; BIOLOGICAL MODEL; CONGESTIVE CARDIOMYOPATHY; HEART FAILURE; IMMUNOLOGY;

CARDIOMYOPATHY, DILATED; CYTOKINES; HEART FAILURE; HUMANS; IMMUNITY, CELLULAR; MODELS, IMMUNOLOGICAL; MYOCARDITIS;

EID: 84878895450     PISSN: 03409937     EISSN: 16156692     Source Type: Journal    
DOI: 10.1007/s00059-012-3700-3     Document Type: Article

References (57)

1. Richardson P, McKenna W, Bristow M et al (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93:841-842
2. McCarthy RE IIIrd, Boehmer JP, Hruban RH et al (2000) Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342:690-695
3. D'Ambrosio A, Patti G, Manzoli A et al (2001) The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85:499-504
4. Di Lenarda A, Pinamonti B, Mestroni L et al (2004) The natural history of dilated cardiomyopathy: a review of the Heart Muscle Disease Registry of Trieste. Ital Heart J Suppl 5:253-266
5. Kindermann I, Kindermann M, Kandolf R et al (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639-648
6. Grogan M, Redfield MM, Bailey KR et al (1995) Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 26:80-84
7. Drory Y, Turetz Y, Hiss Y et al (1991) Sudden unexpected death in persons less than 40 years of age. Am J Cardiol 68:1388-1392
8. Phillips M, Robinowitz M, Higgins JR et al (1986) Sudden cardiac death in Air Force recruits. A 20-year review. JAMA 256:2696-2699
9. Wesslen L, Pahlson C, Lindquist O et al (1996) An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979-1992. Eur Heart J 17:902-910
10. Karjalainen J, Heikkila J (1999) Incidence of three presentations of acute myocarditis in young men in military service. A 20-year experience. Eur Heart J 20:1120-1125
11. Andersson B, Caidahl K, Waagstein F (1995) Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure. Eur Heart J 16:53-60
12. Taylor DO, Stehlik J, Edwards LB et al (2009) Registry of the international society for heart and lung transplantation: twenty-sixth official adult heart transplant report-2009. J Heart Lung Transplant 28:1007-1022
13. Holzmann M, Nicko A, Kühl U et al (2008) Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period. Circulation 118:1722-1728
14. Maisch B, Pankuweit S, Karatolios K, Ristic AD (2006) Invasive techniques - from diagnosis to treatment. Rheumatology (Oxford, England) 45(Suppl 4):iv32-38
15. Aretz HT (1987) Myocarditis: the Dallas criteria. Hum Pathol 18:619-624
16. Strauer BE, Kandolf R, Mall G et al (1996) Myocarditis - cardiomyopathy. Consensus report of the German association for internal medicine, presented at the 100th annual meeting, Wiesbaden, 13 April 1994. Acta Cardiologica 51:347-371
17. Shanes JG, Ghali J, Billingham ME et al (1987) Interobserver variability in the pathologic interpretation of endomyocardial biopsy results. Circulation 75:401-405
18. Hauck AJ, Kearney DL, Edwards WD (1989) Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: implications for role of sampling error. Mayo Clin Proc 64:1235-1245
19. Kühl U, Noutsias M, Seeberg B, Schultheiss HP (1996) Immunohistological evidence for a chronic intramyocardial inflammatory process in dilated cardiomyopathy. Heart 75:295-300
20. Caforio AL, Baboonian C, McKenna WJ (1997) Postviral autoimmune heart disease - fact or fiction? Eur Heart J 18:1051-1055
21. Noutsias M, Seeberg B, Schultheiss HP, Kühl U (1999) Expression of cell adhesion molecules in dilated cardiomyopathy: evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99:2124-2131
22. Maisch B, Bültman B, Factor S et al (1999) World Heart Federation consensus conferences's definition of inflammatory cardiomyopathy (myocarditis): report from two expert commitees on histology and viral cardiomyopathy. Heartbeat 4:3-4
23. Maisch B, Portig I, Ristic A et al (2000) Definition of inflammatory cardiomyopathy (myocarditis): on the way to consensus. A status report. Herz 25:200-209
24. Hufnagel G, Pankuweit S, Richter A et al (2000) The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz 25:279-285
25. Frustaci A, Russo MA, Chimenti C (2009) Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J 30:1995-2002
26. Mahrholdt H, Goedecke C, Wagner A et al (2004) Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 109:1250-1258
27. Baccouche H, Mahrholdt H, Meinhardt G et al (2009) Diagnostic synergy of non-invasive cardiovascular magnetic resonance and invasive endomyocardial biopsy in troponin-positive patients without coronary artery disease. Eur Heart J 30:2869-2879
28. Pankuweit S, Richter A, Ruppert V, Maisch B (2009) Classification of cardiomyopathies and indication for endomyocardial biopsy revisited. Herz 34:55-62
29. Noutsias M, Pauschinger M, Schultheiss HP, Kuhl U (2003) Cytotoxic perforin+and TIA-1+infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy. Eur J Heart Fail 5:469-479
30. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C et al (2001) Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year follow-up results. Circulation 104:39-45
31. Ino T, Kishiro M, Okubo M et al (1997) Late persistent expressions of ICAM-1 and VCAM-1 on myocardial tissue in children with lymphocytic myocarditis. Cardiovasc Res 34:323-328
32. Parrillo JE (2001) Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy? Circulation 104:4-6
33. Noutsias M, Pauschinger M, Ostermann K et al (2002) Digital image analysis system for the quantification of infiltrates and cell adhesion molecules in inflammatory cardiomyopathy. Med Sci Monit 8:MT59-71
34. Noutsias M, Hohmann C, Pauschinger M et al (2003) sICAM-1 correlates with myocardial ICAM-1 expression in dilated cardiomyopathy. Int J Cardiol 91:153-161
35. Noutsias M, Pauschinger M, Schultheiss H, Kühl U (2002) Phenotypic characterization of infiltrates in dilated cardiomyopathy - diagnostic significance of T-lymphocytes and macrophages in inflammatory cardiomyopathy. Med Sci Monit 8:CR478-487
36. Maisch B, Richter A, Sandmoller A et al (2005) Inflammatory dilated cardiomyopathy (DCMI). Herz 30:535-544
37. Klingel K, Hohenadl C, Canu A et al (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 89:314-318
38. Springer TA (1990) Adhesion receptors of the immune system. Nature 346:425-434
39. Noutsias M, Kühl U, Lassner D et al (2007) Parvovirus B19-associated active myocarditis with biventricular thrombi - results of endomyocardial biopsy investigations and cardiac magnetic resonance imaging. Circulation 115:e378-380
40. Wojnicz R, Nowalany-Kozielska E, Wodniecki J et al (1998) Immunohistological diagnosis of myocarditis. Potential role of sarcolemmal induction of the MHC and ICAM-1 in the detection of autoimmune mediated myocyte injury. Eur Heart J 19:1564-1572
41. Matsumoto G, Nghiem MP, Nozaki N et al (1998) Cooperation between CD44 and LFA-1/CD11a adhesion receptors in lymphokine-activated killer cell cytotoxicity. J Immunol 160:5781-5789
42. Mason JW, O'Connell JB, Herskowitz A et al (1995) A clinical trial of immunosuppressive therapy for myocarditis. The myocarditis treatment trial investigators. N Engl J Med 333:269-275
43. Staudt A, Schaper F, Stangl V et al (2001) Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 103:2681-2686
44. Liu PP, Mason JW (2001) Advances in the understanding of myocarditis. Circulation 104:1076-1082
45. Noutsias M, Liu P (2010) Coxsackievirus Induced Murine Myocarditis and Immunomodulatory Interventions. In: Schultheiss HP, Noutsias M eds, Inflammatory Cardiomyopathy (DCMi) - Pathogenesis and Therapy. Birkhäuser, Basel S 51-70
46. Matsumoto Y (2000) Characterization of T cell receptor (TCR) of organ-specific autoimmune disease-inducing T cells and TCR-based immunotherapy with DNA vaccines. J Neuroimmunol 110:1-12
47. Schefe JH, Lehmann KE, Buschmann IR et al (2006) Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J Mol Med (Berlin, Germany) 84:901-910
48. Noutsias M, Rohde M, Block A et al (2008) Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol 9:3
49. Block A, Rohde M, Erben U et al (2008) Impact of cell culture media on the expansion efficiency and T-cell receptor Vbeta (TRBV) repertoire of in vitro expanded T cells using feeder cells. Med Sci Monit 14:BR88-95
50. Peixoto A, Monteiro M, Rocha B, Veiga-Fernandes H (2004) Quantification of multiple gene expression in individual cells. Genome Res 14:1938-1947
51. Kühl U, Pauschinger M, Schwimmbeck PL et al (2003) Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107:2793-2798
52. Noutsias M, Pankuweit S, Maisch B (2009) Pathophysiological mechanisms of parvovirus B19 infection. J Clin Microbiol 47:2358-2359 (author reply 2359
53. Lindner J, Noutsias M, Lassner D et al (2009) Adaptive immune responses against parvovirus B19 in patients with myocardial disease. J Clin Virol 44:27-32
54. Bock CT, Klingel K, Kandolf R (2010) Human parvovirus B19-associated myocarditis. N Engl J Med 362:1248-1249
55. Dennert R, Velthuis S, Schalla S et al (2010) Intravenous immunoglobulin therapy for patients with idiopathic cardiomyopathy and endomyocardial biopsy-proven high PVB19 viral load. Antivir Ther 15:193-201
56. Veinot JP (2002) Diagnostic endomyocardial biopsy pathology - general biopsy considerations, and its use for myocarditis and cardiomyopathy: a review. Can J Cardiol 18:55-65
57. Noutsias M, Pauschinger M, Kühl U, Schultheiss HP (2003) Diagnostic endomyocardial biopsy interpretation. Can J Cardiol 19:98-99 (author reply 99-100)